Amount Raised
90
92
Amount Raised
Growth Score
-5 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
Blackstone Life Sciences is a private equity segment of The Blackstone Group.
- Monica Issar: Senior Managing DirectorPast Role: J.P. Morgan Private Bank, Global Head of Multi-Asset & Portfolio Solutions
Stephen Schwarzman: FounderPast Role: Yale School of Management, Adjunct Professor
Blackstone Group
About the Company
Blackstone Life Sciences (BXLS) operates in the biotechnology sector, focusing on investments in advanced healthcare technologies to improve patient outcomes. The firm invests in both early and late-stage biotechnology and healthcare companies, particularly in therapeutics. BXLS collaborates with pharmaceutical, biotech, and medical technology
companies to aim to address unmet medical needs that have the potential to improve the quality of life for patients around the world.
